Solifenacin and Dolasetron Injection: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Solifenacin
Dolasetron Injection
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
Dolasetron has a dose-dependent effect on QT interval prolongation and has been associated with postmarketing reports of torsade de pointes1. QT interval prolongation and postmarketing cases of torsade de pointes have also been reported with solifenacin. The concomitant use of solifenacin with other drugs that prolong the QT interval should be approached with caution as coadministration may result in additive effects on QT interval prolongation and an increased risk of serious ventricular arrhythmias, including torsade de pointes 2. If coadministration is required, monitoring for QT interval prolongation may be warranted.
Why it happens (mechanism)
Additive effects on QT interval prolongation
Common questions
Can I take Solifenacin and Dolasetron Injection together?
An increased risk of QT interval prolongation Always confirm with your pharmacist or prescriber before making any change.
How serious is the Solifenacin and Dolasetron Injection interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Solifenacin or Dolasetron Injection need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
- Product Information: ANZEMET(R) IV injection, dolasetron mesylate IV injection. Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2011.
- Product Information: VESIcare(R) oral tablets, solifenacin succinate oral tablets. Astellas Pharma US, Inc, Deerfield, IL, 2011. DailyMed
Keep reading about Solifenacin
Keep reading about Dolasetron Injection
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist